Clinical Trial Update: A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating DR30303 in patients with advanced digestive system cancers was terminated; the study assessed safety, tolerability, pharmacokinetics …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Cancer

Drugs mentioned

• DR30303 (DR30303)

Snippet

Sponsor: Zhejiang Doer Biologics Co., Ltd. | Conditions: Malignant Neoplasm of Digestive System | Phase 1 | Status: TERMINATED